BeOne Medicines Ltd. (ONC): Revenue
$5.34B
Year ended 2025-12-31
$6.13B
Trailing 12 months to 2026-06-30
+55.7%
3-year compound annual growth
+76.8%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.34B | +40.2% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $3.81B | +55.0% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $2.46B | +73.7% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $1.42B | +20.4% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $1.18B | +280.8% | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | $308.87M | -27.9% | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | $428.21M | +116.0% | 2021-02-25, From 2019-01-01 |
| 2018-12-31 | $198.22M | -16.8% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $238.39M | n/m | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $1.07M | -87.9% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $8.82M | -32.4% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $13.04M | n/a | 2017-03-22, From 2014-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $5.34B | +40.2% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $4.71B | +6.2% |
| Organon & Co. (OGN) | 2025-12-31 | $6.22B | -2.9% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $4.27B | +4.9% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $4.25B | -2.8% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $3.71B | +65.2% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $3.22B | +12.9% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $3.18B | +10.6% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $3.02B | +8.0% |
Compare ONC, ELAN, OGN, JAZZ side by side · Screen every company in Pharmaceutical Preparations ↗